Evidence map›Paper›PMID 31018479›Full record

ReviewHigh-throughput2019

Mass Spectrometry-Based Methodologies for Targeted and Untargeted Identification of Protein Covalent Adducts (Adductomics): Current Status and Challenges.

João Nunes, Catarina Charneira, Judit Morello, João Rodrigues, Sofia A Pereira, Alexandra M M Antunes

Abstract readReview
In one paragraph

Review in High-throughput, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Toxicology reports · 2021
    Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

João NunesCentro de Química Estrutural, Instituto Superior Técnico, ULisboa, 1049-001 Lisboa, Portugal. joaopcnunes@tecnico.ulisboa.pt.
Catarina CharneiraCentro de Química Estrutural, Instituto Superior Técnico, ULisboa, 1049-001 Lisboa, Portugal. catarina.charneira@tecnico.ulisboa.pt.
Judit MorelloCentro de Química Estrutural, Instituto Superior Técnico, ULisboa, 1049-001 Lisboa, Portugal. judit.morello@tecnico.ulisboa.pt.
João RodriguesClarify Analytical, Rua dos Mercadores 128A, 7000-872 Évora, Portugal. joao.rodrigues@clarifyanalytical.pt.
Sofia A PereiraCEDOC, Chronic Diseases Research Centre, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, 1169-006 Lisboa, Portugal. sofia.pereira@nms.unl.pt.
Alexandra M M AntunesCentro de Química Estrutural, Instituto Superior Técnico, ULisboa, 1049-001 Lisboa, Portugal. alexandra.antunes@tecnico.ulisboa.pt.

Funding

COMPETE SAICTPAC/0019/2015Fundação para a Ciência e a Tecnologia (FCT) UID/QUI/00100/2013,SFRH/BD/102846/2014, SFRH/BD/140157/2018, SAICTPAC/0019/2015, RNEM-LISBOA-01-0145-FEDER-022125
6 · The paper itself

Abstract

Protein covalent adducts formed upon exposure to reactive (mainly electrophilic) chemicals may lead to the development of a wide range of deleterious health outcomes. Therefore, the identification of protein covalent adducts constitutes a huge opportunity for a better understanding of events underlying diseases and for the development of biomarkers which may constitute effective tools for disease diagnosis/prognosis, for the application of personalized medicine approaches and for accurately assessing human exposure to chemical toxicants. The currently available mass spectrometry (MS)-based methodologies, are clearly the most suitable for the analysis of protein covalent modifications, providing accuracy, sensitivity, unbiased identification of the modified residue and conjugates along with quantitative information. However, despite the huge technological advances in MS instrumentation and bioinformatics tools, the identification of low abundant protein covalent adducts is still challenging. This review is aimed at summarizing the MS-based methodologies currently used for the identification of protein covalent adducts and the strategies developed to overcome the analytical challenges, involving not only sample pre-treatment procedures but also distinct MS and data analysis approaches.

Indexed as

adductomicsmass spectrometryprotein covalent adducts

Identifiers

PMID31018479
PMCPMC6631461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.